Journal Abbreviation: BLOOD CANCER J Journal ISSN: 2044-5385 YearImpact Factor (IF)Total ArticlesTotal Cites 2023 (2024 update)12.9876925 202212.8-6523 20219.812-5662 202011.037874691 20198.023652800 20187.895692247 20178.125581804 20166.126541270 20154.41156790 ...
Pediatric Blood & Cancer Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 1545-5009.
This journal has been indexed by ESCI and is planned to be indexed by SCIE, with an expected high impact factor. 《血癌发现》是由美国癌症研究学会(AACR)出版的国际同行评审期刊,专注于血液系统疾病的基础、转化和临床研究。该期刊旨在发表在血液病领域具有重大发现及较大影响力的研究内容,推动血液病研究...
Furthermore, validation of the 2022 ELN prognostic impact in a real-life cohort could be helpful to support its use in the routine clinical practice. This study aims to compare and validate the 2022 ELN and 2017 ELN risk classifications in a large real-life series of newly diagnosed AML ...
Tumor-specific mutations can result in immunogenic neoantigens, both of which have been correlated with responsiveness to immune checkpoint inhibitors in highly mutagenic cancers. However, early results of single-agent checkpoint inhibitors in multiple m
Ding X, Ding J, Gu H, Zhong C. Long-acting granulocyte colony-stimulating factor in primary prophylaxis of early infection in patients with newly diagnosed multiple myeloma. Support Care Cancer. 2022;30:4049–54. PubMedPubMed Central
Impact of Serum Insulin-Like Growth Factor 1 on Hematopoietic Stem Cell Transplantation Outcome in Pediatric Cancer Patients Deborah Betzmann, Michaela Döring, Gunnar Blumenstock, Friederike Erdmann, ... Gerhard BinderJuly 2022 Pages 355.e1-355.e9 View PDF Article preview select article 391 - Ant...
Speeckaert, in Advances in Clinical Chemistry, 2022 4.1 ABO blood group The ABO gene, located on the 9th chromosome, consists of 7 exons and codes for enzyme glycosyltransferases, which are responsible for the formation of antigens in blood type A and/or B [120]. Driven by the ...
Ding X, Ding J, Gu H, Zhong C. Long-acting granulocyte colony-stimulating factor in primary prophylaxis of early infection in patients with newly diagnosed multiple myeloma. Support Care Cancer. 2022;30:4049–54. PubMedPubMed CentralGoogle Scholar ...
(n = 1123). At diagnosis, the median age was 65 years and with male predominance (3:2) and is comparable to US census data where the median age was reported to be 68 years (https://www.cancer.org/cancer/acute-myeloid-leukemia/about.html,https://seer.cancer.gov/statfacts/html/...